Oculis appoints Björn Tackenberg as chief scientific officer
OCS•Oculis appointed Björn Tackenberg chief scientific officer. He will lead global scientific strategy, prioritizing Privosegtor's PIONEER program and potential applications in acute multiple sclerosis relapses.
1. Leadership appointments
Tackenberg previously headed Integrative Neuroscience & Medical Practice at Roche. Aaron Tansy recently joined Oculis as vice president, development franchise head, neurology, after serving as executive medical director, clinical development at PTC Therapeutics.
